Close
Close
Treatment Database
6'-(R)-methyl-5-O-(5-amino-5,6-dideoxy-alpha-L-talofuranosyl)-paromamine sulfate
Trade Name not avaiable
Orphan Indication Cystic fibrosis
EU Market Approval
EU Designation Date 26-10-2018
Sponsor FGK Representative Service GmbH
More about Cystic fibrosis
Free Newsletter
Related Videos